Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United Kingdom (current)IrelandUnited StatesNew ZealandCanadaAustraliaScotlandNorthern Ireland

Company · Macclesfield

Medicines Discovery Catapult Limited

Research and experimental development on biotechnology

How am I connected?
More
View network map Report an issue

Official record Companies House · updated 27th September 2026 · Sources

Network

The large node is Medicines Discovery Catapult Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 12

  1. Professor Madeline Parsons 2025-2025 Director View profile
  2. Alistair John Macdonald 2020-2025 Director View profile
  3. Professor Christopher Richard Molloy 2016-2026 Director View profile
  4. Peter Jon Kellner 2016-2018 Director View profile
  5. Professor Carole Margaret Longson 2016-2025 Director View profile
  6. Sir Alexander Fred Markham 2016-2025 Director View profile
  7. Dr Clive James Dix 2016-2023 Director View profile
  8. Katherine Margaret Bellingham 2016-2019 Director View profile
  9. Dr Christopher Fintan Reilly 2016-2025 Director View profile
  10. Professor Clive Dylan Morris 2016-2021 Director View profile
  11. Graham John Boulnois 2016-2018 Director View profile
  12. Robert Kenneth Bryan 2015-2018 Director View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

About

What it does
Research and experimental development on biotechnology
Incorporated
23/12/2015
Registered office
Macclesfield
Previous names
Medicines Technologies Catapult Limited (until 01/03/2016)

Ownership

Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.

  • Graham John Boulnois ceased 2018-05-24
    25-50% voting · notified 2018-02-12
  • Possible match - name could not be confirmed to one individualiPossible matchThis PSC filing could not be confirmed to one individual. Not shown as confirmed ownership.

Group

  1. Medicines Discovery Catapult Limited is controlled by Graham John Boulnois
    Evidence
    ceased 25-50% voting · notified 2018-02-12, ceased 2018-05-24 · source: Companies House PSC register

Ultimately controlled by Graham John Boulnois.

4 other companies in this group

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Grants received

44 grants · £94,765,786 total

360Giving data, published by funders. Coverage only includes funders who publish their grants to 360Giving, so these figures are a floor, not a complete picture.

Top funders

  • Department for Business, Energy and Industrial Strategy · £65,645,365 (23 grants)
  • Department for Science, Innovation and Technology · £29,120,422 (21 grants)

Most recent

  • Department for Science, Innovation and Technology £96,3892024-04-01
  • Department for Science, Innovation and Technology £300,0002024-01-19
  • Department for Science, Innovation and Technology £30,7222024-01-04
  • Department for Science, Innovation and Technology £467,0932024-01-04
  • Department for Science, Innovation and Technology £590,8782023-11-24

Contracts awarded

6 contracts · £3,250,000 total

From Contracts Finder and Find a Tender (Open Government Licence v3.0), where this organisation is recorded as the buyer. Suppliers are matched to a Governance Register company or charity page at confidence 0.7 or higher; below that they are shown by name only.

Top suppliers

  • Unknown supplier · £3,250,000 (6 contracts)

Most recent

Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

8 directors on the board

4.4y median 5y
average tenure
8y
longest tenure

Directors past 6 years

First-time vs portfolio directors

Portfolio (8)

Left in the last 12 months

Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.

Professional services 19Other services 3Health and social care 2Education 1Tech and media 1

The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.

Gaps to watch

  • Several long-serving directors could step down together

Where to look Suggested search: succession planning for long-tenured seats.

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
09928547
Status
Active
Type
PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Accounts next due
31/12/2027
Edition
Register edition compiled 27th September 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data